Shevtsov, M; Stangl, S; Nikolaev, B; Yakovleva, L; Marchenko, Y; Tagaeva, R; Sievert, W; ... Multhoff, G; + view all Shevtsov, M; Stangl, S; Nikolaev, B; Yakovleva, L; Marchenko, Y; Tagaeva, R; Sievert, W; Pitkin, E; Mazur, A; Tolstoy, P; Galibin, O; Ryzhov, V; Steiger, K; Smirnov, O; Khachatryan, W; Chester, K; Multhoff, G; - view fewer (2019) Granzyme B Functionalized Nanoparticles Targeting Membrane Hsp70‐Positive Tumors for Multimodal Cancer Theranostics. Small , 15 (13) , Article 1900205. 10.1002/smll.201900205.

Preview

Text Chester_MS_Shevtsov et al_revision 1_saved changes.pdf - Accepted Version Download (866kB) | Preview

Abstract

Functionalized superparamagnetic iron oxide nanoparticles (SPIONs) have emerged as potential clinical tools for cancer theranostics. Membrane‐bound 70 kDa heat shock protein (mHsp70) is ubiquitously expressed on the cell membrane of various tumor types but not normal cells and therefore provides a tumor‐specific target. The serine protease granzyme B (GrB) that is produced as an effector molecule by activated T and NK cells has been shown to specifically target mHsp70 on tumor cells. Following binding to Hsp70, GrB is rapidly internalized into tumor cells. Herein, it is demonstrated that GrB functionalized SPIONs act as a contrast enhancement agent for magnetic resonance imaging and induce specific tumor cell apoptosis. Combinatorial regimens employing stereotactic radiotherapy and/or magnetic targeting are found to further enhance the therapeutic efficacy of GrB‐SPIONs in different tumor mouse models.

Download activity - last month

Export as JSONCSVXML

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as CSVXMLJSON

Archive Staff Only

View Item